BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27203393)

  • 1. PTRF suppresses the progression of colorectal cancers.
    Wang F; Zheng Y; Orange M; Yang C; Yang B; Liu J; Tan T; Ma X; Chen T; Yin X; Tang X; Zhu H
    Oncotarget; 2017 Jul; 8(30):48650-48659. PubMed ID: 27203393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
    Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
    Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
    Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
    Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.
    Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD
    Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling.
    El-Daly SM; Abba ML; Patil N; Allgayer H
    Sci Rep; 2016 Apr; 6():24720. PubMed ID: 27095166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
    Qin A; Qian W
    Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA‑187 is an independent prognostic factor in lung cancer and promotes lung cancer cell invasion via targeting of PTRF.
    Peng J; Liu HZ; Zhong J; Deng ZF; Tie CR; Rao Q; Xu W; You T; Li J; Cai CB; Lu Q; Liu W; Zhang Y; Lei ZY
    Oncol Rep; 2016 Nov; 36(5):2609-2618. PubMed ID: 27634346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
    Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J
    Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
    Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
    Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
    Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
    Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
    Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA-binding protein ESRP1 promotes human colorectal cancer progression.
    Fagoonee S; Picco G; Orso F; Arrigoni A; Longo DL; Forni M; Scarfò I; Cassenti A; Piva R; Cassoni P; Silengo L; Tolosano E; Aime S; Taverna D; Pandolfi PP; Brancaccio M; Medico E; Altruda F
    Oncotarget; 2017 Feb; 8(6):10007-10024. PubMed ID: 28052020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
    Zhao Q; Xu L; Sun X; Zhang K; Shen H; Tian Y; Sun F; Li Y
    Tumour Biol; 2017 Jun; 39(6):1010428317707881. PubMed ID: 28653875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer.
    Moon H; Lee CS; Inder KL; Sharma S; Choi E; Black DM; Lê Cao KA; Winterford C; Coward JI; Ling MT; ; Craik DJ; Parton RG; Russell PJ; Hill MM
    Oncogene; 2014 Jul; 33(27):3561-70. PubMed ID: 23934189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
    Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C
    PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.
    Wu XB; Liu Y; Wang GH; Xu X; Cai Y; Wang HY; Li YQ; Meng HF; Dai F; Jin JD
    Sci Rep; 2016 Feb; 6():21420. PubMed ID: 26892992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer.
    Yu H; Ye W; Wu J; Meng X; Liu RY; Ying X; Zhou Y; Wang H; Pan C; Huang W
    Clin Cancer Res; 2014 Jul; 20(13):3434-45. PubMed ID: 24771643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.